Axsome Therapeutics, Inc. revenue breakdown overview

Axsome Therapeutics, Inc. revenue for the last year amounted to 385.69 M USD, the most of which — 385.69 M USD — came from its highest performing source at the moment, Novel Therapies for the Management of Central Nervous System Disorders, the year earlier bringing 270.60 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Axsome Therapeutics, Inc. 378.16 M USD, and the year before that — 197.22 M USD.